FindTrial
Sign In

Atrial electrophysiological study guided by three-dimensional mapping system combined with noninvasive ECG indexes to explore the electrophysiological changes of atrial cardiomyopathy and predictive value for prognosis

Atrial electrophysiological study guided by three-dimensional mapping system combined with noninvasive ECG indexes to explore the electrophysiological changes of atrial cardiomyopathy and predictive value for prognosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056465
Enrollment
Unknown
Registered
2022-02-06
Start date
2022-02-06
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial cardiomyopathy

Interventions

Atrial fibrillation group:none
non-atrial fibirllaiton group:none

Sponsors

The First Affiliated Hospital of Dalian Medical Universit
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing left atrial procedure in radiofrequency ablation of arrhythmias (preexcitation syndrome, supraventricular tachycardia, paroxysmal atrial fibrillation).

Exclusion criteria

Exclusion criteria: 1. Complicated with organic heart disease, such as cardiomyopathy, coronary heart disease, rheumatic heart disease; 2. Electrolyte disorder; 3. Hyperthyroidism; 4. Congenital heart disease; 5. Moderate to severe valvular disease; 6. Previously received cardiac surgery.

Design outcomes

Primary

MeasureTime frame
atrial refractory period;sinus node recovery time;P wave electrical axis;—

Countries

China

Contacts

Public ContactSun Yuanjun

The First Affiliated Hospital of Dalian Medical University

yuanjunsun@126.com+86 411 83635863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026